Catch Potential Mishaps With Mayzent for Advanced Multiple Sclerosis

Mayzent (siponimod) will be a new oral med for adults with an advanced form of multiple sclerosis (MS).

About half of patients with relapsing-remitting MS will develop worsening symptoms within 10 years...called secondary progressive multiple sclerosis.

Expect Mayzent to be saved for patients who progress despite other multiple sclerosis treatments (interferon beta, etc).

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 120+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote